HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,256,606 | +6.9% | 81,007 | +1.6% | 0.00% | +50.0% |
| Q2 2023 | $6,786,170 | +4.5% | 79,706 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $6,496,456 | +6.4% | 78,507 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $6,104,815 | +6.8% | 77,620 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $5,716,000 | +11.9% | 77,214 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $5,109,000 | +9.3% | 78,384 | +6.0% | 0.00% | +100.0% |
| Q1 2022 | $4,675,000 | +19.6% | 73,945 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $3,909,000 | -24.7% | 73,713 | +0.2% | 0.00% | -50.0% |
| Q3 2021 | $5,192,000 | +21.2% | 73,553 | +14.5% | 0.00% | +100.0% |
| Q2 2021 | $4,283,000 | -66.5% | 64,263 | -44.2% | 0.00% | -80.0% |
| Q1 2021 | $12,794,000 | -6.0% | 115,249 | +0.5% | 0.01% | 0.0% |
| Q4 2020 | $13,614,000 | +18.1% | 114,646 | -13.3% | 0.01% | 0.0% |
| Q3 2020 | $11,532,000 | +5.4% | 132,171 | +8.2% | 0.01% | 0.0% |
| Q2 2020 | $10,945,000 | +18.5% | 122,209 | +31.8% | 0.01% | 0.0% |
| Q1 2020 | $9,238,000 | -14.5% | 92,688 | -1.5% | 0.01% | 0.0% |
| Q4 2019 | $10,811,000 | -0.6% | 94,094 | +9.1% | 0.01% | -16.7% |
| Q3 2019 | $10,875,000 | +5.7% | 86,212 | +0.8% | 0.01% | 0.0% |
| Q2 2019 | $10,291,000 | +98.3% | 85,516 | +44.1% | 0.01% | +100.0% |
| Q1 2019 | $5,190,000 | -11.3% | 59,335 | +1.5% | 0.00% | -40.0% |
| Q4 2018 | $5,849,000 | -8.6% | 58,456 | +4.6% | 0.01% | 0.0% |
| Q3 2018 | $6,402,000 | +26.1% | 55,877 | -1.3% | 0.01% | +25.0% |
| Q2 2018 | $5,075,000 | -37.4% | 56,599 | -49.0% | 0.00% | -33.3% |
| Q1 2018 | $8,107,000 | +31.8% | 110,980 | +4.8% | 0.01% | +50.0% |
| Q4 2017 | $6,153,000 | +30.8% | 105,917 | +0.9% | 0.00% | 0.0% |
| Q3 2017 | $4,703,000 | +19.3% | 104,958 | +5.1% | 0.00% | +33.3% |
| Q2 2017 | $3,943,000 | +6.4% | 99,893 | +9.4% | 0.00% | 0.0% |
| Q1 2017 | $3,706,000 | +1.8% | 91,350 | +0.8% | 0.00% | 0.0% |
| Q4 2016 | $3,641,000 | +107.7% | 90,617 | +86.7% | 0.00% | +50.0% |
| Q3 2016 | $1,753,000 | +371.2% | 48,533 | +274.1% | 0.00% | – |
| Q2 2016 | $372,000 | -7.9% | 12,974 | +11.5% | 0.00% | – |
| Q1 2016 | $404,000 | +14.1% | 11,638 | +7.0% | 0.00% | – |
| Q4 2015 | $354,000 | +10.6% | 10,879 | +9.2% | 0.00% | – |
| Q3 2015 | $320,000 | -22.5% | 9,958 | 0.0% | 0.00% | – |
| Q2 2015 | $413,000 | +1.5% | 9,958 | +10.1% | 0.00% | – |
| Q1 2015 | $407,000 | +42.8% | 9,045 | +22.9% | 0.00% | – |
| Q4 2014 | $285,000 | +8.8% | 7,358 | -2.1% | 0.00% | – |
| Q3 2014 | $262,000 | – | 7,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |